Published in Ann Clin Res on April 01, 1978
The effect of single doses of penbutolol and propranolol L.A. on psychomotor performance. Br J Clin Pharmacol (1984) 0.79
Penbutolol or hydrochlorothiazide once a day in hypertension. A controlled study with home measurements. Br J Clin Pharmacol (1981) 0.75
Haemodynamic dose-response effects of i.v. penbutolol in angina pectoris. Br J Clin Pharmacol (1983) 0.75
Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med (1992) 5.65
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation (1992) 4.96
Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study. Br Med J (Clin Res Ed) (1984) 3.62
Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA (1988) 2.89
Measurement of the angina threshold using atrial pacing. A new technique for the study of angina pectoris. Cardiovasc Res (1967) 2.84
Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care (1992) 1.75
Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol (1999) 1.70
Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis (1991) 1.66
Relationship of skeletal muscle fiber type to serum high density lipoprotein cholesterol and apolipoprotein A-I levels. Atherosclerosis (1991) 1.56
Lp(a) lipoprotein and pre-beta1-lipoprotein in patients with coronary heart disease. Clin Genet (1974) 1.54
Combined parasympathetic and beta-receptor blockade as a clinical test. Acta Med Scand (1967) 1.51
Accuracy and precision of quantitative arteriography in the evaluation of coronary artery disease after coronary bypass surgery. A validation study. Int J Card Imaging (1994) 1.39
The Helsinki Heart Study: an 8.5-year safety and mortality follow-up. J Intern Med (1994) 1.20
A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension. Br J Clin Pharmacol (1986) 1.13
The Helsinki Heart Study: coronary heart disease incidence during an extended follow-up. J Intern Med (1994) 1.09
The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J Clin Invest (1996) 1.06
Progression of coronary artery disease in randomized medical and surgical patients over a 5-year angiographic follow-up. Am J Cardiol (1983) 1.04
Serum ferritin and ceruloplasmin as coronary risk factors. Eur Heart J (1994) 1.00
Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension. Br Med J (1976) 0.99
Modulation of coronary tone in acute myocardial infarction by endothelin. Lancet (1989) 0.98
Patency of sequential versus single vein grafts in coronary bypass surgery. Thorac Cardiovasc Surg (1982) 0.98
Ultrasonic measurements of left ventricular wall thickness. Chest (1970) 0.96
Prevention of early reocclusion by dipyridamole and ASA in arterial reconstructive surgery. J Cardiovasc Surg (Torino) (1981) 0.96
The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial. Atherosclerosis (1998) 0.95
Regional myocardial perfusion abnormalities on xenon-133 imaging in patients with angina pectoris and normal coronary arteries. Am J Cardiol (1977) 0.93
Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study. Atherosclerosis (1994) 0.92
The mechanism of bradycardia evoked by physical training. Cardiologia (1967) 0.92
Genetic variation in serum low density lipoproteins and lipid levels in man. Proc Natl Acad Sci U S A (1976) 0.92
Serum lipids in angiographically assessed coronary atherosclerosis. Chest (1978) 0.92
Changes in native coronary arteries after coronary bypass surgery. Role of graft patency, serum lipids and hypertension. Am J Cardiol (1975) 0.91
Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators. J Clin Invest (1998) 0.90
Survival with total occlusion of the left main coronary artery. Significance of the collateral circulation. Cathet Cardiovasc Diagn (1979) 0.90
Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment. Atherosclerosis (2001) 0.89
9-alpha-fluorohydrocortisone in the treatment of postural hypotension. Acta Med Scand (1966) 0.89
Once daily versus twice daily beta-blockers: effects on arrhythmias and hypertension. Lancet (1980) 0.87
Comparison of verapamil and practolol in paroxysmal supraventricular tachycardia. Eur J Cardiol (1976) 0.87
Effect of aorto-coronary grafts and native vessel patency on the occurrence of angina pectoris after coronary bypass surgery. Br Heart J (1975) 0.86
Analysis of coronary collaterals in ischaemic heart disease by angiography during pacing induced ischaemia. Br Heart J (1976) 0.86
Combined dihydralazine and propranolol in the treatment of hypertension. Int Z Klin Pharmakol Ther Toxikol (1970) 0.85
The Helsinki Heart Study: basic design and randomization procedure. Eur Heart J (1987) 0.85
Insufficient cardiorespiratory response to exercise secondary to central nervous system lesions. Acta Med Scand (1966) 0.84
Seasonal variation in high density lipoprotein cholesterol. Atherosclerosis (1993) 0.84
Persistent improvement after coronary bypass surgery: ergometric and angiographic correlations at 5 years. Circulation (1983) 0.84
Long-term efficacy and safety of pimobendan in moderate heart failure. A double-blind parallel 6-month comparison with enalapril. The Pimobendan-Enalapril Study Group. Eur Heart J (1994) 0.83
Lp(a) lipoprotein/pre-beta1-lipoprotein, serum lipids and atherosclerotic disease. Clin Genet (1976) 0.83
Angiographic findings in patients exhibiting ischemia after oral dipyridamole. Int J Cardiol (1989) 0.82
Effect of pindolol and propranolol on renal function of patients with hypertension. Br J Clin Pharmacol (1982) 0.82
Supravalvular pulmonic stenosis, abnormal facial appearance, and mental retardation. Am Heart J (1968) 0.82
Sequential internal mammary artery (IMA) grafts in coronary artery bypass surgery. Thorac Cardiovasc Surg (1984) 0.81
Direct hospital costs in coronary bypass surgery. Ann Chir Gynaecol (1985) 0.81
Work status after coronary bypass surgery. A prospective randomized study with ergometric and angiographic correlations. Acta Med Scand (1979) 0.81
General and local contraindications for endosseal implants--an epidemiological panoramic radiograph study in 65-year-old subjects. Community Dent Oral Epidemiol (1995) 0.80
Mitral valve replacement with ball and tilting disc valve prosthesis. A clinical and haemodynamic study. Scand J Thorac Cardiovasc Surg (1976) 0.80
An appraisal of symptom relief after coronary bypass grafting. Postgrad Med J (1976) 0.80
Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study. Am J Cardiol (1989) 0.79
Letter: Serum-H.D.L. in a therosclerotic heart-disease. Lancet (1976) 0.79
Cigarette smoking is associated with elevated adrenal androgen response to adrenocorticotropin. J Steroid Biochem Mol Biol (1993) 0.79
Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol. Circulation (1998) 0.79
The Helsinki Heart Study: central findings and clinical implications. Ann Med (1991) 0.79
The effect of dipyridamole and warfarin on the patency rate of coronary artery bypass grafts. Thorac Cardiovasc Surg (1983) 0.79
Assessment of the effect of long-term dipyridamole in angina pectoris by atrial pacing and physical exercise. Ann Clin Res (1971) 0.79
Long-term excess physical activity and central haemodynamics in man. Adv Cardiol (1976) 0.78
Cardiovascular dimensions and moderate physical training in young men. J Appl Physiol (1970) 0.78
Modification of digitalis-induced electrocardiographic changes by propranolol and potassium. Ann Clin Res (1972) 0.78
Efficacy of conventional and sustained-release verapamil in stable angina pectoris. Ann Med (1992) 0.78
Persistence of improved exercise tolerance and degree of revascularization after coronary bypass surgery. A prospective randomized study. Clin Cardiol (1979) 0.78
A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT Study. Lopid Coronary Angiography Trial. Control Clin Trials (1997) 0.77
Leukocytes as a coronary risk factor in a dyslipidemic male population. Am Heart J (1992) 0.77
Double-blind titrated-dose comparison of metoprolol and propranolol in the treatment of angina pectoris. Ann Clin Res (1976) 0.77
Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy. Thromb Haemost (2000) 0.77
A new electrical equipment for handgrip testing. Ann Clin Res (1979) 0.77
Prevention of deep venous thrombosis and thrombo-embolism by dipyridamole and acetylsalicylic acid after reconstructive arterial surgery. J Cardiovasc Surg (Torino) (1980) 0.77
T-wave alternans associated with heart failure and hypomagnesemia in alcoholic cardiomyopathy. Eur J Cardiol (1975) 0.76
Effect of gemfibrozil on the concentration and composition of serum lipoproteins. A controlled study with special reference to initial triglyceride levels. Atherosclerosis (1990) 0.76
Twice-daily pindolol and alprenolol in essential hypertension of moderate severity. Ann Clin Res (1976) 0.75
Carditis associated with coronavirus infection. Lancet (1980) 0.75
Lipoproteins and coronary heart disease in the Helsinki Heart Study. Eur Heart J (1990) 0.75
Conversion of paroxysmal atrial fibrillation to sinus rhythm by intravenous pirmenol. A placebo controlled study. Br Heart J (1986) 0.75
Efficiency of a pacemaker clinic to prevent sudden pacing failures. Br Heart J (1973) 0.75
Coronary implications of hemodynamic changes caused by physical training. Am J Cardiol (1968) 0.75
A two-year circulatory follow-up of physical training after myocardial infarction. Acta Med Scand (1970) 0.75
Cardio-selective beta-adrenergic inhibition by practolol in angina pectoris. Fortn Rev Chic Dent Soc (1970) 0.75
Pirmenol in the long-term treatment of chronic ventricular arrhythmias: a placebo-controlled study. J Cardiovasc Pharmacol (1986) 0.75
Resurrection. South Med J (1982) 0.75
[Follow-up of patients with implantable pacemakers]. Duodecim (1970) 0.75
Efficacy and tolerability of isradipine and metoprolol in treatment of hypertension: the Finnish Isradipine Study in Hypertension (FISH). J Cardiovasc Pharmacol (1992) 0.75
Rapidity of the hypotensive effect of short-acting nitrous compounds. Ann Clin Res (1969) 0.75
Prosthetic possibilities using endosseal implants as anchorages--an epidemiological study in 65-year-old subjects. J Oral Rehabil (1995) 0.75
[Cardiogenic shock and its treatment]. Duodecim (1965) 0.75
The effect of physical training in manifest ischemic heart disease. Circulation (1969) 0.75
[Reply to Ilka Vuori's article "The effects of physical exercise on the structure and function of the heart" (Sotla I/66)]. Sotilaslaak Aikak (1966) 0.75
The response of heart volume and ventricular functions to physical training in coronary heart disease. Mal Cardiovasc (1969) 0.75
Supravalvular pulmonic stenosis. Am Heart J (1968) 0.75
[Monitoring and treatment hemodynamics]. Duodecim (1990) 0.75
The spectrum of cardiac capacity in patients with nonobstructive congenital heart disease. Am J Cardiol (1966) 0.75
A double-blind comparison of indoramin and pindolol added to hydrochlorothiazide for the treatment of mild to moderate hypertension. J Cardiovasc Pharmacol (1986) 0.75
Effect of physical training on left ventricular systole. Cardiologia (1967) 0.75
[Adam-Stokes syndrome and its conservative treatment]. Duodecim (1970) 0.75